For more than 80 years, Draper has delivered new capabilities to support U.S. national security. In often challenging environments, when lives are on the line, your technologies have to work.
Many of the tools and capabilities delivered for our national security customers may be applied to solve challenges in the commercial sector. With three areas of emphasis and dozens more sectors relying on Draper, we help ensure your market advantage.
Biomedical Solutions
Automotive
Environmental Solutions
Related Solutions
End-to-end Bioprocessing System
How is Draper making cell and gene therapy processing more efficient and cost-effective to expand patient access?
Energy Distribution
How can Draper increase operational efficiency of networked key infrastructure while providing robust security assurance?
Connected Medical Devices
How does Draper’s expertise enable reliable medical platforms for the internet of things?
DMS - Breath Analyzer
How does Draper’s portable, highly sensitive chemical detection system identify disease in breath?
BIOMIMETICS
How can we predict the effects of drugs on multiple-organ systems in humans using human tissue?
EVIDENT
How can Draper’s microfluidics help preclinical researchers to pinpoint effective immunotherapies for cancer?
Related News
Autonomous Systems
Draper Awarded Patent for Novel Electric Motor in Development
Biomedical Solutions
Draper Signs Agreement with Kite to Accelerate Development of Cancer Immunotherapies
Autonomous Systems
Draper Inventors Honored for Single-Photon Detector
Technology could benefit LiDAR, surveillance, bioscience, imaging and quantum communications
Materials Engineering & Microfabrication
Draper Is Developing a Noncontact Sensor that Measures the Body’s Hidden 3D Bioelectric Field
Human-centered Solutions
Draper’s New Driver Assist Tech Can ‘See’ Pedestrians
PathScout detects cell phone signals to zero in on pedestrian and vehicle traffic
Biomedical Solutions
Draper Demonstrates Miniature Organ Models Can Play Key Role in COVID-19 Drug Development
New article in bioRxiv points to potential use of organ-on-a-chip in drug discovery for COVID-19 and seasonal flu
Related Press
Access our Capabilities
We push boundaries and deliver the capabilities you need.